This article is more than 5 years old. Information may no longer be current.

Feasibility study shows dual-optic accommodating IOL clinically effective

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SEATTLE — A dual-optic accommodating IOL was found to be “safe and stable,” according to one investigator’s study in a small number of eyes.

Ivan L. Ossma-Gomez, MD, MPH, reported that early postoperative data from eyes implanted with Visiogen’s Synchrony IOL showed that uncorrected vision improved in all cases.

Dr. Ossma-Gomez reported here at the ASCRS Summer Refractive Congress on 28 eyes implanted with the accommodative IOL for which he had more than 12 months follow-up.

Early results indicate that 82% of eyes achieved 20/40 or better uncorrected distance visual acuity, and 100% achieved 20/40 or better uncorrected near visual acuity.

“This is a promising technology. It is safe and stable over time in the first 2 years with accommodating amplitudes of over 2.75 D as can be measured at this time,” he said.

Dr. Ossma-Gomez said further results will be reported at the European Society of Cataract and Refractive Surgeons meeting in September.